Specialty Pharmacy

Ninety-three percent of B-cell acute lymphoblastic leukemia patients treated went into remission in small study.

Top news of the day from across the health care landscape.

Improved cancer detection rates and a reduced recall rates can be enhanced.

Ocaliva approved in combination with ursodeoxycholic acid (UDCA) or as a monotherapy for adults who can’t tolerate UDCA.

Researchers evaluate patient preferences in the treatment of rheumatoid arthritis.

Good bacteria prevented from working effectively in some inflammatory bowel disease patients.

Growing number of patients with life-threatening liver disease being removed from transplant waiting lists.

Long-term exposure to particulate matter increases mortality risk from cancer.

New method may help overcome barriers in patient recruitment to clinical trials.

Top news of the day from across the healthcare landscape.

Patients with multiple myeloma receiving ASCT showed a 10% increase in tumor cell reduction.

Fluciclovine F 18 (Axumin) is a radioactive diagnostic agent that can be used to detect recurring prostate cancer.

Researchers evaluate why HIV-infected individuals have lower magnitude responses to flu vaccines.

Out-of-pocket limits significantly higher under ACA bronze and silver plans than with employer-based plans.

CRISPR/Cas9 gene editing system shows promise eliminating HIV.

Treatment delays prevent tight blood sugar control in type 2 diabetes patients.

The underlying mechanisms of the immune system may lead to new treatments for COPD and lupus.

Study findings may help determine why inflammatory bowel disease patients have a chronic type of inflammation.

Some cancer patients treated with doxorubicin will experience heart damage.

The PI3K/AKT pathway may provide a new therapeutic target for breast cancer combination therapy.

Liver tumors found to stop using fructose.

Discovering lung cancer in the early stage shows significant survival benefits.

Anxiety can cause men with prostate cancer to forgo surveillance for chemotherapy.

Top news of the week from The American Journal of Pharmacy Benefits.

Researchers found that 80% of HIV-positive patients had increased aortic inflammation after starting antiretroviral therapy.

Recent advances and updates in oncology and cancer drug development.

MAAT could assist cancer survivors with overcoming memory problems and lessen anxiety associated with memory dysfunction.

Genetic variation can cause severe acute pancreatitis from chemotherapy in patients with acute lymphoblastic leukemia (ALL).